Lorazepam: Difference between revisions
No edit summary |
No edit summary |
||
| Line 31: | Line 31: | ||
|LORA03 | |LORA03 | ||
|P1S1S3 & Part 1 Dangerous Drug | |P1S1S3 & Part 1 Dangerous Drug | ||
|} | |||
==Mechanism of Action== | |||
*Lorazepam is a benzodiazepine. | |||
*Gama-Aminobutyric acid (GABA) is an inhibitory neurotransmitter, acting on the GABA receptors in the central nervous system (CNS), thus inhibiting the nerve impulses. | |||
*It acts on the benzodiazepine receptors in the brain and the spinal cord. Benzodiazepine receptors in the CNS are linked with GABA receptors as a complex. | |||
*Lorazepam by binding to the benzodiazepine receptors results in activation of the GABA-benzodiazepine receptor complex, resulting in inhibition of nerve impulses, overall depression of brain and spinal cord. | |||
*The anticonvulsant properties of lorazepam come from binding to sodium channels. | |||
==Dosage== | |||
{| class="wikitable" | |||
!style="text-align: left"| Anxiety | |||
|By ''mouth | |||
ADULT: | |||
*1 – 4 mg daily in divided doses | |||
ELDERLY: | |||
*0.5 – 2 mg daily in divided doses | |||
|- | |||
!style="text-align: left"| Insomnia associated with anxiety | |||
|By ''mouth | |||
ADULT: | |||
1 – 2 mg daily, to be taken at bedtime | |||
|- | |||
!style="text-align: left"| Acute panic attacks | |||
| By ''mouth | |||
ADULT: | |||
*25 – 30 micrograms/kg every 6 hours if required; | |||
*Usual dose: 1.5 – 2.5 mg every 6 hours if required | |||
|- | |||
!style="text-align: left"| Conscious sedation for procedures | |||
|By ''mouth | |||
ADULT: | |||
*2 – 3 mg to be taken the night before operation | |||
*2 – 4 mg to be taken 1 – 2 hours before operation | |||
|- | |||
!style="text-align: left"| Premedication | |||
| By ''mouth | |||
*2 – 3 mg to be taken the night before operation | |||
*2 – 4 mg to be taken 1 – 2 hours before operation | |||
|- | |||
!style="text-align: left"| Status epilepticus | |||
Febrile convulsions | |||
Convulsions due to poisoning | |||
| By ''slow intravenous injection'' | |||
CHILD 1 month – 11 years: | |||
100 micrograms/kg (max. per dose 4 mg) for 1 dose, then 100 micrograms/kg after 10 minutes (max. per dose 4 mg) if required for 1 dose, to be administered into a large vein | |||
CHILD 12 – 17 years: | |||
4 mg for 1 dose, then 4 mg after 10 minutes if required for 1 dose, to be administered into a large vein | |||
ADULT: | |||
4 mg for 1 dose, then 4 mg after 10 minutes if seizures continue or recur | |||
|- | |||
!style="text-align: left"| Chemotherapy-induced nausea and vomiting | |||
| By ''mouth | |||
ADULTS: | |||
ADULT: 1 to 2 mg may be added to antiemetic therapy with domperidone or metoclopramide for the prophylaxis of nausea and vomiting. | |||
|} | |||
Revision as of 01:40, 12 October 2020
Lorazepam(中文:[[ ]]) is a short-acting benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant properties. It is used:
- In the short-term treatment of severe anxiety disorders;
- As a hypnotic in the short-term treatment of insomnia;
- As an anticonvulsant (particularly in the management of status epilepticus and febrile convulsions)
- As a sedative for those who are being mechanically ventilated
- Chemotherapy-induced nausea and vomiting
Pronunciation
Lorazepam 0.5mg
Lorazepam 1mg
Drug Names
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Lorazepam Tablet 0.5 mg | LORA01 | P1S1S3 & Part 1 Dangerous Drug |
| Lorazepam Tablet 1 mg | LORA02 | P1S1S3 & Part 1 Dangerous Drug |
| Lorazepam Tablet 2 mg | LORA03 | P1S1S3 & Part 1 Dangerous Drug |
Mechanism of Action
- Lorazepam is a benzodiazepine.
- Gama-Aminobutyric acid (GABA) is an inhibitory neurotransmitter, acting on the GABA receptors in the central nervous system (CNS), thus inhibiting the nerve impulses.
- It acts on the benzodiazepine receptors in the brain and the spinal cord. Benzodiazepine receptors in the CNS are linked with GABA receptors as a complex.
- Lorazepam by binding to the benzodiazepine receptors results in activation of the GABA-benzodiazepine receptor complex, resulting in inhibition of nerve impulses, overall depression of brain and spinal cord.
- The anticonvulsant properties of lorazepam come from binding to sodium channels.
Dosage
| Anxiety | By mouth
ADULT:
ELDERLY:
|
|---|---|
| Insomnia associated with anxiety | By mouth
ADULT: 1 – 2 mg daily, to be taken at bedtime |
| Acute panic attacks | By mouth
ADULT:
|
| Conscious sedation for procedures | By mouth
ADULT:
|
| Premedication | By mouth
|
| Status epilepticus
Febrile convulsions Convulsions due to poisoning |
By slow intravenous injection
CHILD 1 month – 11 years: 100 micrograms/kg (max. per dose 4 mg) for 1 dose, then 100 micrograms/kg after 10 minutes (max. per dose 4 mg) if required for 1 dose, to be administered into a large vein CHILD 12 – 17 years: 4 mg for 1 dose, then 4 mg after 10 minutes if required for 1 dose, to be administered into a large vein ADULT: 4 mg for 1 dose, then 4 mg after 10 minutes if seizures continue or recur |
| Chemotherapy-induced nausea and vomiting | By mouth
ADULTS: ADULT: 1 to 2 mg may be added to antiemetic therapy with domperidone or metoclopramide for the prophylaxis of nausea and vomiting. |
